Making sense: markets from stories in new breast cancer therapeutics

New Genetics and Society · Published 2025-04-16 · DOI 10.1080/14636778.2025.2492849

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1080/14636778.2025.2492849

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns · New Genetics and Society · 2022 · Same journal
• Use of tissue and health data: attachments and detachments among an enabling public · New Genetics and Society · 2023 · Same journal
• The unexpected and unanticipated announcement of the “world’s first” gene edited babies: breaching, repairing and strengthening community boundaries · New Genetics and Society · 2022 · Same journal
• Commoning contingent resources: constructing an Australian stem cell registry · New Genetics and Society · 2025 · Same journal
• Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations · New Genetics and Society · 2022 · Same journal
• Environmental sustainability and biobanking: a pilot study of the field · New Genetics and Society · 2022 · Same journal
• Promising precision medicine: how patients, clinicians and caregivers work to realize the potential of genomics-informed cancer care · New Genetics and Society · 2021 · Same journal
• Governance through scientism: Taiwan Biobank and public controversy · New Genetics and Society · 2022 · Same journal
• Correction · New Genetics and Society · 2025 · Same journal
• Past-futures in experimental care: breast cancer and HIV medicine · New Genetics and Society · 2021 · Same journal